Profusa signs option to acquire G3 Vision Labs; G3 had ~$111M 2025 revenue

Profusa, Inc.

Option to acquire G3 Vision Labs and its subsidiaries (Med Screen, Dominion, Acutis) for equity consideration.
G3's unaudited 2025 net revenues ~$111M; combined entity would be a public diagnostics company.
Conditions: Profusa must raise at least $30M in financing, obtain stockholder approval, refinance G3 debt.
As option consideration, Profusa issued 201,120 common shares and 52,904 Series A Preferred shares (convertible to common 1:1000).
Company believes it now meets Nasdaq minimum stockholders' equity of $2.5M for continued listing.

item 1.01 item 5.03 item 3.02 item 7.01 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.